Key result
PROMUS Element everolimus-eluting stent shows a 6.2% one-year target vessel failure rate in real-world use.
Why the study?
Outcomes following PROMUS Element everolimus-eluting stent implantation in an unselected patient population were not well characterized.
Does PROMUS Element everolimus-eluting stent implantation provide favorable outcomes in an unselected real-world patient population?
Observational (n=1,010)
Open-label
Yes
Does PROMUS Element everolimus-eluting stent implantation provide favorable outcomes in an unselected real-world patient population?
The PROMUS Element everolimus-eluting stent demonstrates favorable one-year outcomes with low event rates in a complex, real-world patient population.
No takes yet. Share an insight, caveat, or question.
Supports favorable real-world performance; leaves open need for randomized confirmation before changing practice.
Thomas et al. (2015) conducted an observational in Coronary artery disease requiring stenting (n=1,010). PROMUS Element everolimus-eluting stent was evaluated on target vessel failure. Implantation of the PROMUS Element everolimus-eluting stent in an unselected real-world population resulted in a one-year target vessel failure rate of 6.2%.
Synapse has enriched one closely related paper. Consider it for comparative context: